| AMPAR | α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor |
| AD | Alzheimer’s Disease |
| APP | Amyloid Precursor Protein |
| ApoER2 | Apolipoprotein E receptor 2 |
| AP2 | Clathrin adaptor protein |
| ASD | Autism Spectrum Disorder |
| A2RE | A2 response element |
| BBB | blood–brain barrier |
| Cdk5 | CiclinA2-dependent kinase 5 |
| CRMP-2 | Collapsin response mediator protein-2 |
| CDT | Carboxy-terminal domains |
| CNS | Central Nervous System |
| DAB1 | Intracellular adaptor protein |
| GAP-domain | GTPase activating domain |
| GRIP1/2 | Glutamate receptor interacting proteins 1 and 2 |
| GSK3β | Glycogen synthase kinase 3 beta |
| HI | Hypoxic–ischemia |
| HnRNP A2 | Heterogeneous nuclear ribonucleoprotein A2 |
| IPT | Immunoglobulin-plexin-transcription domain |
| LTP | Long-term potential |
| L-VGCC | L-type voltage-gated calcium channel |
| MAG | Myelin-associated glycoprotein |
| MAP | Microtubule-associated proteins |
| MBP | Myelin basic protein |
| MGLUR | Metabotropic glutamate receptor |
| MS | Multiple sclerosis |
| NGF | Nerve Growth Factor |
| NMDA | N-methyl-d-aspartate |
| NMDAR | N-methyl-d-aspartate receptor |
| NRTK | Non-Receptor Tyrosine Kinase |
| OL | Oligodendrocytes |
| OTK | Off-track kinases |
| PD | Parkinson Disease |
| PDGF | Platelet-Derived Growth factor |
| PLP | Proteolipid protein |
| PP1,PP2 | Pyrazolopyrimidine |
| PrPC | Prion protein |
| PSD | Postsynaptic density |
| PSI | Plexin-semaphorin-integrin domain |
| PYK2 | Protein tyrosine kinase 2 beta |
| ROS | Reactive oxygen species |
| RPTPα | Receptor-like Protein Tyrosine Phosphatase α |
| RSV | Rous’ virus |
| SFK | Src Family Kinases |
| SNPs | Single nucleotide polymorphisms |
| STEP | Striatal Enriched Phosphatase |
| TK | Tyrosine Kinase |
| VLDL-R | Very-low density lipoprotein receptor |
| Γ-FCR | Γ-chain of immunoglobulin receptor |